ClinicalTrials.govpublic full text
Sodium-glucose Cotransporter Type 2 Inhibitors for Acute Cardiorenal Syndrome Prevention
congestive heart failure, heart failure, decompensation, gliflozins, kidneys, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 853909
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.